Table 1.
Usually indolent | |
---|---|
T-cell large granular lymphocytic leukemia | |
Hydroa vacciniforme-like lymphoproliferative disorder | |
Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract | |
Subcutaneous panniculitis-like T-cell lymphoma | |
Mycosis fungoides | |
Primary cutaneous CD30-positive T-cell lymphoproliferative disorders Lymphomatoid papulosis Primary cutaneous anaplastic large cell lymphoma Primary cutaneous acral CD8-positive T-cell lymphoma Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder | |
Breast implant–associated anaplastic large cell lymphoma | |
Usually aggressive | |
Nodal | Extranodal |
Systemic EBV-positive T-cell lymphoma of childhood | Extranodal NK/T-cell lymphoma, nasal type |
Adult T-cell leukemia/lymphoma | Enteropathy-associated T-cell lymphoma |
Peripheral T-cell lymphoma, not otherwise specified | Monomorphic epitheliotropic intestinal T-cell lymphoma |
Angioimmunoblastic T-cell lymphoma | Hepatosplenic T-cell lymphoma |
Follicular T-cell lymphoma | Sézary syndrome |
Nodal peripheral T-cell lymphoma with TFH phenotype | Primary cutaneous gamma-delta T-cell lymphoma |
Anaplastic large cell lymphoma Anaplastic lymphoma kinase positive Anaplastic lymphoma kinase negative |
Primary cutaneous CD 8–positive aggressive epidermotropic cytotoxic T-cell lymphoma |
Typically leukemic presentation | |
T-cell prolymphocytic leukemia | |
Chronic lymphoproliferative disorder of NK cells | |
Aggressive NK-cell leukemia |
Abbreviations: EBV, Epstein-Barr virus; NK, natural killer; TFH, follicular helper T; WHO, World Health Organization.